GLPwatch
Trials (2101)
Page 25 of 36.
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
- Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
- SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
- The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
- A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
- Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- Blood Pressure Outcomes With Liraglutide Therapy
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- Dietary Peanuts and Nutrition-Related Outcomes
- Glutide for Ending Methamphetamine
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
- A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
- SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
- Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
- GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
- A Study of LY3457263 in Obese Participants
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
- A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
- Prognostic Predictors of Response to Hypoglycemic Therapy
- Saxenda in Obesity Services (STRIVE Study)
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
- Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
- GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
- Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
- Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
- The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
- Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
- A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
- A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
- Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
- Effect of Tirzepatide on Brown Adipose Tissue in Obesity
- Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity
- Antiproteinuric Effects of Liraglutide Treatment